Monday, November 4, 2019

Mirati Therapeutics EPS misses by $0.13, beats on revenue

Mirati Therapeutics (NASDAQ:MRTX): Q3 GAAP EPS of -$1.38 misses by $0.13.
Revenue of $0.99M beats by $0.78M.
Shares +1.05%.
Press Release
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.